Back to search

T-cell immunity to the joining region of p210BCR-ABL protein.

Data up to Jan 2025

Published1992
Citations184
References37

Total Citations Per Year

Abstract

References (37)

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

1985 • 1,650 citations

The Basis for the Immunoregulatory Role of Macrophages and Other Accessory Cells

1987 • 1,040 citations

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity

1984 • 913 citations

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

1977 • 888 citations

The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene

1986 • 820 citations

Acute leukaemia in bcr/abl transgenic mice

1990 • 701 citations

A sequence pattern common to T cell epitopes.

1988 • 623 citations

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

1990 • 535 citations

Immunology: The ins and outs of antigen processing and presentations

1986 • 498 citations

A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia

1987 • 448 citations

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.

1987 • 380 citations

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

1991 • 353 citations

Unique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALL

1987 • 344 citations

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.

1985 • 295 citations

A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia

1987 • 278 citations

An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.

1984 • 210 citations

The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity

1985 • 184 citations

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.

1989 • 145 citations

T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.

1991 • 126 citations

Antigen Processing for Presentation to T Lymphocytes: Function, Mechanisms, and Implications for the T-Cell Repertoire

1988 • 105 citations

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.

1986 • 97 citations

Evidence that the phl gene encodes a 160,000-dalton phosphoprotein with associated kinase activity.

1987 • 84 citations

Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia

1991 • 82 citations

Selective Transformation of Primitive Lymphoid Cells by the BCR/ABL Oncogene Expressed in Long-Term Lymphoid or Myeloid Cultures

1988 • 80 citations

Anti-peptide antibodies detect oncogene-related proteins in urine.

1985 • 76 citations

Late-appearing Philadelphia chromosome in two patients with chronic myelogenous leukemia

1980 • 69 citations

Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia.

1989 • 68 citations

Identical peptides recognized by MHC class I- and II-restricted T cells.

1989 • 63 citations

Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia

1987 • 59 citations

BCR-ABL and BCR proteins: biochemical characterization and localization.

1990 • 53 citations

T lymphocytes lack rearrangement of the bcr gene in Philadelphia chromosome-positive chronic myelocytic leukemia

1987 • 48 citations

How T Cells see Antigen

1989 • 46 citations

Baculovirus expression of functional P210 BCR-ABL oncogene product.

1989 • 39 citations

Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.

1986 • 37 citations

Alternative Forms of the BCR-ABL Oncogene Have Quantitatively Different Potencies for Stimulation of Immature Lymphoid Cells

1989 • 30 citations

Immunologic characterization of the tumor-specific bcr-abl junction in Philadelphia chromosome-positive acute lymphoblastic leukemia

1990 • 17 citations

Chronic Myelogenous Leukemia: Molecular Approaches to Research and Therapy

1992 • 15 citations

Cited By (0)

No citing papers found in database

T-cell immunity to the joining region of p210BCR-ABL protein. (1992) – Proceedings of the National Academy of Sciences | Metascience Observatory Explorer